European Journal of Biomedical and Pharmaceutical Sciences

MUCORMYCOSIS -“THE BLACK CLOUDS ADMIST THE VIRAL STORM”

Dr. G.N Srivastava, *Dr. Aparna Suresh, Dr. Aiyush Jain, Dr. Gowthami Balu, Dr. Arya Krishnan,
Dr. Shivam Dixit

ABSTRACT

As our country battles against an aggressive waves of covid 19 infection,the growing incidence of mucormycosis is emerging as a matter of major concern amoung doctors pan india.India bears the flagholder for being the diabetes ‘CAPITAL ”of the world .COVID 19 and its cocktail treatment with steroids at the helm against this background creates a perfect environment for mucormycosis. The fungal infection clinically referred as mycormycosis also zygomycosis are common infections to human where causative agent i.e., Mucoromycotina is member of mucorales. The causative agent mucoromycotina habitats in soil and decaying organic matter.[3] The cases of mycormycosis are not new however; a spike in such cases has been reported during COVID era. Although all the sequelae and complications of COVID-19 are yet to be documented and described, spike in secondary infections are being increasingly recognized worldwide.[1]

Keywords: .